Literature DB >> 19005481

Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells.

A Knödler1, S M Schmidt, A Bringmann, M M Weck, K M Brauer, T A W Holderried, A-K Heine, F Grünebach, P Brossart.   

Abstract

Toll-like receptors (TLRs) act to sense the environment for microbial products and submit danger signals to antigen-presenting cells (APCs) resulting in activation of complex immune responses. In this study, we analyzed the function of human monocyte-derived APCs generated in vitro in the presence of interleukin (IL)-10 upon activation by TLR ligands. Exposure of these APCs to IL-10 resulted in a skewed phenotypic maturation in response to stimuli provided by the TLR ligands, a reduced cytokine production, such as IL-12, IL-6 or tumor necrosis factor-alpha, and impaired capacity to stimulate T-cell activation. Furthermore, CCR7 upregulation in APCs exposed to TLR stimulation as well as migration towards CCL19/MIP-3beta were strongly reduced. IL-10 was found to downregulate MyD88, IRAK1 (IL-1 receptor-associated kinase) and tumor necrosis factor receptor-associated factor 6, essential adaptor molecules for TLR signaling, and to decrease TLR-induced nuclear expression of the nuclear factor-kappaB transcription factors c-Rel and Rel-B as well as interferon regulatory factor (IRF)-3 and IRF-8. This was not due to the inhibition of the mitogen-activated protein kinase pathway, but was rather mediated by the blockage of the PI3K signaling cascade. Interestingly, the inhibition of proteins involved in TLR signaling, such as MyD88, IRAK1 and mammalian target of rapamycin, was due to a selective post-transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005481     DOI: 10.1038/leu.2008.301

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

1.  Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.

Authors:  Jihoon Chang; Steven L Kunkel; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

2.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

3.  Generation and functional characterization of MDSC-like cells.

Authors:  Annkristin Heine; Stefanie Andrea Erika Held; Jonas Schulte-Schrepping; Julia Friederike Andrea Wolff; Kathrin Klee; Thomas Ulas; Niklas Arndt Schmacke; Solveig Nora Daecke; Kati Riethausen; Joachim L Schultze; Peter Brossart
Journal:  Oncoimmunology       Date:  2017-02-23       Impact factor: 8.110

4.  Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b.

Authors:  Graziella Curtale; Massimiliano Mirolo; Tiziana Ada Renzi; Marzia Rossato; Flavia Bazzoni; Massimo Locati
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

5.  Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

Authors:  Brian Ruffell; Debbie Chang-Strachan; Vivien Chan; Alexander Rosenbusch; Christine M T Ho; Nancy Pryer; Dylan Daniel; E Shelley Hwang; Hope S Rugo; Lisa M Coussens
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

6.  IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9.

Authors:  Jui-Hung Yen; Weimin Kong; Doina Ganea
Journal:  J Immunol       Date:  2010-02-26       Impact factor: 5.422

7.  IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.

Authors:  Ruchi Roy; Janet Zayas; Mohamed F Mohamed; Anahita Aboonabi; Kaylee Delgado; Jennillee Wallace; Mohammad Bayat; Timothy M Kuzel; Jochen Reiser; Sasha H Shafikhani
Journal:  J Invest Dermatol       Date:  2021-09-10       Impact factor: 7.590

Review 8.  GPNMB: a potent inducer of immunosuppression in cancer.

Authors:  Anna-Maria Lazaratos; Matthew G Annis; Peter M Siegel
Journal:  Oncogene       Date:  2022-09-01       Impact factor: 8.756

9.  CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model.

Authors:  Lam Quoc Bao; Nguyen Tien Huy; Mihoko Kikuchi; Tetsuo Yanagi; Masachika Senba; Mohammed Nasir Shuaibu; Kiri Honma; Katsuyuki Yui; Kenji Hirayama
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.

Authors:  Mario Hubo; Bettina Trinschek; Fanny Kryczanowsky; Andrea Tuettenberg; Kerstin Steinbrink; Helmut Jonuleit
Journal:  Front Immunol       Date:  2013-04-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.